Blog
RSS FeedPosted by Michael Wonder on 16 Oct 2017
Cancer groups want to stop classifying disease by the body part it grows in
16 October 2017 - They are the breakthrough medicines turning cancer from a death sentence into a chronic disease but ...
Posted by Michael Wonder on 13 Oct 2017
Hundreds of patients to have access to head and neck cancer drug after new deal, says NICE
13 October 2017 - Nivolumab is recommended for use within the Cancer Drugs Fund for some patients with head and neck ...
Posted by Michael Wonder on 13 Oct 2017
Hunt puts best foot forward on health but we’ll need to monitor developments
13 October 2017 - Health Minister Greg Hunt today unveiled the most significant reforms to private health funds in recent ...
Posted by Michael Wonder on 13 Oct 2017
At last, good news on health insurance
13 October 2017 - The wide-ranging health insurance reforms announced today deliver a welcome response to consumer dissatisfaction with the ...
Posted by Michael Wonder on 13 Oct 2017
Decision to fund dexamethasone implants (Ozurdex)
13 October 2016 - PHARMAC is pleased to announce the approval of an agreement with Allergan for the listing of ...
Posted by Michael Wonder on 13 Oct 2017
Major reforms to make private health insurance simpler and more affordable
13 October 2017 - The Australian Government has announced a wide ranging package of reforms to make private health insurance simpler ...
Posted by Michael Wonder on 12 Oct 2017
Health care: the measure of a robust system
13 October 2017 - For all its faults, for all the times that things don’t go as planned, Australia’s health system ...
Posted by Michael Wonder on 12 Oct 2017
Health insurers’ billion dollar remedy
13 October 2017 - Australia’s health insurers have backed the most comprehensive reforms to hit the industry in almost 20 ...
Posted by Michael Wonder on 12 Oct 2017
Missing out on cancer drugs
12 October 2017 - A letter to the Editor of the New Zealand Herald from the Managing Director of MSD ...
Posted by Michael Wonder on 12 Oct 2017
New treatment option for people with gastro-intestinal cancer
12 October 2017 - More people will be able to receive regorafenib now that NICE has said it should move out ...
Posted by Michael Wonder on 12 Oct 2017
Health fund premiums to be reined in under sweeping Turnbull government changes
12 October 2017 - Private health insurers will be able to charge higher excesses and offer discounts to under-30s under ...
Posted by Michael Wonder on 11 Oct 2017
CDR Update — Issue 129
11 October 2017 - In August 2017, CADTH invited stakeholder comments and feedback on a proposal to revise the resubmission ...
Posted by Michael Wonder on 11 Oct 2017
Study finds significant overlap in the drugs covered by Canadian public drug plans
11 October 2017 - The Patented Medicine Prices Review Board, through the National Prescription Drug Utilisation Information System research initiative, ...
Posted by Michael Wonder on 11 Oct 2017
Xeljanz receives positive reimbursement decision in England
11 October 2017 - The UK’s HTA body NICE has provided final guidance recommending Xeljanz (tofacitinib citrate) as a treatment ...
Posted by Michael Wonder on 11 Oct 2017
Obesity related diseases expected to cost Australia $21 billion
11 October 2017 - Without action on obesity, the economic burden of treating obesity related diseases is estimated to rise from ...